Search research articles
Contact Us
Filters
Showing results (21-30 of 61) with videos related to
Page
of 7
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
May 22, 2019
The role of orexin-1 receptor signaling in demand for the opioid fentanyl
Jennifer E Fragale, Caroline B Pantazis, Morgan H James, et al.
Brain Research
|
October 25, 2016
Orexin/hypocretin-1 receptor antagonism reduces ethanol self-administration and reinstatement selectively in highly-motivated rats
David E Moorman, Morgan H James, Elisabeth A Kilroy, et al.
Addiction Biology
|
July 13, 2019
The number of lateral hypothalamus orexin/hypocretin neurons contributes to individual differences in cocaine demand
Caroline B Pantazis, Morgan H James, Brandon S Bentzley, et al.
The European Journal of Neuroscience
|
September 22, 2018
Demand elasticity predicts addiction endophenotypes and the therapeutic efficacy of an orexin/hypocretin-1 receptor antagonist in rats
Morgan H James, Hannah E Bowrey, Colin M Stopper, et al.
Brain Research
|
December 23, 2014
Differential roles of medial prefrontal subregions in the regulation of drug seeking
David E Moorman, Morgan H James, Ellen M McGlinchey, et al.
Frontiers in Behavioral Neuroscience
|
October 14, 2014
Electrophysiological characteristics of paraventricular thalamic (PVT) neurons in response to cocaine and cocaine- and amphetamine-regulated transcript (CART)
Jiann Wei Yeoh, Morgan H James, Brett A Graham, et al.
Current Topics in Behavioral Neurosciences
|
December 25, 2016
A Decade of Orexin/Hypocretin and Addiction: Where Are We Now?
Morgan H James, Stephen V Mahler, David E Moorman, et al.
The International Journal of Neuropsychopharmacology
|
October 17, 2013
Clinical staging: a necessary step in the development of improved animal models of mood disturbance?
Frederick Rohan Walker, Morgan H James, Ian B Hickie, et al.
Artificial Intelligence Chemistry
|
March 13, 2024
Machine learning models to predict ligand binding affinity for the orexin 1 receptor
Vanessa Y Zhang, Shayna L O'Connor, William J Welsh, et al.
British Journal of Pharmacology
|
September 24, 2024
Contribution of hypothalamic orexin (hypocretin) circuits to pathologies of motivation
Aida Mohammadkhani, Caitlin Mitchell, Morgan H James, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 61) with videos related to
Sort By:
Page
of 7
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
May 22, 2019
The role of orexin-1 receptor signaling in demand for the opioid fentanyl
Jennifer E Fragale, Caroline B Pantazis, Morgan H James, et al.
Brain Research
|
October 25, 2016
Orexin/hypocretin-1 receptor antagonism reduces ethanol self-administration and reinstatement selectively in highly-motivated rats
David E Moorman, Morgan H James, Elisabeth A Kilroy, et al.
Addiction Biology
|
July 13, 2019
The number of lateral hypothalamus orexin/hypocretin neurons contributes to individual differences in cocaine demand
Caroline B Pantazis, Morgan H James, Brandon S Bentzley, et al.
The European Journal of Neuroscience
|
September 22, 2018
Demand elasticity predicts addiction endophenotypes and the therapeutic efficacy of an orexin/hypocretin-1 receptor antagonist in rats
Morgan H James, Hannah E Bowrey, Colin M Stopper, et al.
Brain Research
|
December 23, 2014
Differential roles of medial prefrontal subregions in the regulation of drug seeking
David E Moorman, Morgan H James, Ellen M McGlinchey, et al.
Frontiers in Behavioral Neuroscience
|
October 14, 2014
Electrophysiological characteristics of paraventricular thalamic (PVT) neurons in response to cocaine and cocaine- and amphetamine-regulated transcript (CART)
Jiann Wei Yeoh, Morgan H James, Brett A Graham, et al.
Current Topics in Behavioral Neurosciences
|
December 25, 2016
A Decade of Orexin/Hypocretin and Addiction: Where Are We Now?
Morgan H James, Stephen V Mahler, David E Moorman, et al.
The International Journal of Neuropsychopharmacology
|
October 17, 2013
Clinical staging: a necessary step in the development of improved animal models of mood disturbance?
Frederick Rohan Walker, Morgan H James, Ian B Hickie, et al.
Artificial Intelligence Chemistry
|
March 13, 2024
Machine learning models to predict ligand binding affinity for the orexin 1 receptor
Vanessa Y Zhang, Shayna L O'Connor, William J Welsh, et al.
British Journal of Pharmacology
|
September 24, 2024
Contribution of hypothalamic orexin (hypocretin) circuits to pathologies of motivation
Aida Mohammadkhani, Caitlin Mitchell, Morgan H James, et al.
Page
of 7